3Suzuki T,Yamazaki T,Yazaki Y.The role of the natriuretic peptides in the cardiovascular system[J] .Cardiovasc Res,2001,51(3):489-494.
4Khan SQ,Dhillon OS,O'Brien RJ,et al.C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction:Leicester Acute Myocardial Infarction Peptide (LAMP) study[J] .Circulation,2007,115 (16):2103-2110.
5Lindahl B,Venge P,Wallentin L.Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease[J] .Circulation,1996,93(9):1651-1657.
7Palazzuoli A,Deckers J,Calabrò A,et al.Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function[J] .Am J Cardiol,2006,98(10):1322-1328.
8LaPointe MC.Molecular regulation of the brain natriuretic peptide gene[J] .Peptides,2005,26(6):944-956.
9Ndrepepa G,Braun S,Mehilli J,et al.Accuracy of N-terminal probrain natriuretic peptide to predict mortality or detect acute ischemia in patients with coronary artery disease[J] .Cardiology,2008,109(4):249-257.
10Scirica BM,Cannon CP,Sabatine MS,et al.Concentrations of Creactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death[J] .Clin Chem,2009,55 (2):265-273.
